$0.980600
-0.02-1.94%
At Close: -
$1.02
0.044.02%
After Hours: 9:25 AM EDT
15 minutes delayed
CARISMA Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of CARISMA Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.27 | $-0.30 | 10.0 % |
Mar 2024 | 2024-05-09 | $-0.46 | $-0.43 | -6.98 % |
Mar 2024 | 2024-04-01 | $-0.52 | $-0.55 | 5.45 % |
Sep 2023 | 2023-11-09 | $-0.53 | $-0.57 | 7.02 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $9.20M | $3.92M | 134.6 % |
Mar 2024 | 2024-05-09 | $3.40M | $4.40M | -22.8 % |
Mar 2024 | 2024-04-01 | $4.29M | $2.90M | 47.9 % |
Sep 2023 | 2023-11-09 | $3.83M | $1.20M | 218.9 % |
CARISMA Therapeutics (CARM) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.27, which beat the estimate of $-0.30.
The Actual Revenue was $9.2M, which beat the estimate of $3.9M.
Browse earnings estimates, EPS, and revenue on all stocks.